亚宝药业 (600351)
Yabao Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 70000.00
- Circulating A-Shares(W): 70000.00
- Earnings Per Share(RMB): 0.3066
- Net Assets Per Share(RMB): 3.9939
- Operating Revenue(W RMB): 170871.22
- Total Profit(W RMB): 25336.40
- **Net Profit Attributable to Parent(W RMB) **: 21509.43
- Net Profit Growth Rate(%): -8.44
- Weighted Return on Equity(%): 7.5200
- Operating Cash Flow Per Share(RMB): 0.6520
- Undistributed Profit Per Share(RMB): 1.7957
- Capital Reserve Per Share(RMB): 0.8494
2. Main Business
The main business covers:
- Production and sales of Chinese and Western medicine preparations
- Production and sales of chemical synthetic bulk drugs
3. Company Basic Information
- Company Name: Yabao Pharmaceutical Group Co., Ltd.
- Listing Date: 2002-09-26
- Industry: Pharmaceutical Manufacturing
- Address: Floor 11, Building 2, No. 11 Yard, Tianhua North Street, Beijing Economic-Technological Development Area
- Website: https://www.yabao.com.cn
- Company Profile: Approved by the relevant laws and regulations including the "Company Law of the People's Republic of China," and authorized by the Shanxi Provincial People's Government Document Jin Zheng Han (1998) No. 172 "Reply on Approving the Establishment of Shanxi Yabao Pharmaceutical Group Co., Ltd.", the company was established on January 26, 1999. It was initiated by Shanxi Ruicheng Pharmaceutical Factory as the main sponsor, jointly with four other legal entities: Shanxi Provincial Economic Construction Investment Company, Shanxi Provincial Science and Technology Fund Development General Company, Datong Traditional Chinese Medicine Factory, and Shanxi Provincial Economic and Trade Assets Management Co., Ltd.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanxi Yabao Investment Group Co., Ltd. | General Legal Person | 9430.00 | 13.47 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 3074.63 | 4.39 |
| 3 | Datong Traditional Chinese Medicine Factory | General Legal Person | 622.00 | 0.89 |
| 4 | Industrial Securities Asset Management - Huayuan Land Port Capital Operation Co., Ltd. - Industrial Securities Asset Management Alpha Kerui No. 106 Single Asset Management Plan | Asset Management Plan | 475.00 | 0.68 |
| 5 | ChinaAMC SSE Traditional Chinese Medicine ETF | Fund | 436.21 | 0.62 |
| 6 | Longkou Jiayuan Wolfman Auto Parts Co., Ltd. | General Legal Person | 406.26 | 0.58 |
5. Concept Sectors
- Baby & Child Concept
- Vitamins
- Helicobacter Pylori
- Innovative Drugs
- Margin Trading & Securities Lending
- High Dividend Stocks
- Share Buyback Plan
- Free Cash Flow
- CSI Share Buybacks
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information
